BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35360105)

  • 1. Circulating Monocyte-Like Myeloid Derived Suppressor Cells and CD16 Positive Monocytes Correlate With Immunological Responsiveness of Tuberculosis Patients.
    Amiano NO; Pellegrini JM; Morelli MP; Martinena C; Rolandelli A; Castello FA; Casco N; Ciallella LM; de Casado GC; Armitano R; Stupka J; Gallego C; Palmero DJ; García VE; Tateosian NL
    Front Cell Infect Microbiol; 2022; 12():841741. PubMed ID: 35360105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease.
    Grassi G; Vanini V; De Santis F; Romagnoli A; Aiello A; Casetti R; Cimini E; Bordoni V; Notari S; Cuzzi G; Mosti S; Gualano G; Palmieri F; Fraziano M; Goletti D; Agrati C; Sacchi A
    Front Immunol; 2021; 12():594376. PubMed ID: 33981297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to
    Namdev P; Patel S; Sparling B; Garg A
    Front Immunol; 2021; 12():647019. PubMed ID: 33995365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
    Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
    Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted Gene Expression Profiling of Human Myeloid Cells From Blood and Lung Compartments of Patients With Tuberculosis and Other Lung Diseases.
    Kotze LA; van der Spuy G; Leonard B; Penn-Nicholson A; Musvosvi M; McAnda S; Malherbe ST; Erasmus M; Scriba T; Koegelenberg CFN; Allwood BW; Walzl G; du Plessis N
    Front Immunol; 2022; 13():839747. PubMed ID: 35356003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis.
    Magcwebeba T; Dorhoi A; du Plessis N
    Front Immunol; 2019; 10():917. PubMed ID: 31114578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed/infected with Mycobacterium tuberculosis.
    Du Plessis N; Jacobs R; Gutschmidt A; Fang Z; van Helden PD; Lutz MB; Hesseling AC; Walzl G
    Eur J Immunol; 2017 Jan; 47(1):107-118. PubMed ID: 27861788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Antimicrobial Activity of Monocytic Myeloid-Derived Suppressor Cells in Infection with Mycobacterium tuberculosis and Human Immunodeficiency Virus.
    Garg A
    Methods Mol Biol; 2021; 2236():115-127. PubMed ID: 33237545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Frequencies of Intermediate Monocyte Subsets Among Individuals Infected With Drug-Sensitive or Drug-Resistant
    Sampath P; Natarajan AP; Moideen K; Kathamuthu GR; Hissar S; Dhanapal M; Jayabal L; Ramesh PM; Tripathy SP; Ranganathan UD; Babu S; Bethunaickan R
    Front Immunol; 2022; 13():892701. PubMed ID: 35911760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report.
    Davids M; Pooran A; Smith L; Tomasicchio M; Dheda K
    Front Immunol; 2021; 12():676679. PubMed ID: 34149712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
    Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
    mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis and myeloid-derived suppressor cells: Insights into caveolin rich lipid rafts.
    Kotzé LA; Young C; Leukes VN; John V; Fang Z; Walzl G; Lutz MB; du Plessis N
    EBioMedicine; 2020 Mar; 53():102670. PubMed ID: 32113158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of autophagy mediators in myeloid-derived suppressor cells during human tuberculosis.
    Kotze LA; Leukes VN; Fang Z; Lutz MB; Fitzgerald BL; Belisle J; Loxton AG; Walzl G; du Plessis N
    Cell Immunol; 2021 Nov; 369():104426. PubMed ID: 34469846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for
    Munansangu BSM; Kenyon C; Walzl G; Loxton AG; Kotze LA; du Plessis N
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer.
    Tavukcuoglu E; Horzum U; Yanik H; Uner A; Yoyen-Ermis D; Nural SK; Aydin B; Sokmensuer C; Karakoc D; Yilmaz KB; Hamaloglu E; Esendagli G
    Eur J Immunol; 2020 Dec; 50(12):2067-2074. PubMed ID: 32691408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells.
    Nagatani Y; Funakoshi Y; Suto H; Imamura Y; Toyoda M; Kiyota N; Yamashita K; Minami H
    J Cancer Res Ther; 2021; 17(4):1093-1100. PubMed ID: 34528569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis.
    Rovetta AI; Peña D; Hernández Del Pino RE; Recalde GM; Pellegrini J; Bigi F; Musella RM; Palmero DJ; Gutierrez M; Colombo MI; García VE
    Autophagy; 2014; 10(12):2109-21. PubMed ID: 25426782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability.
    Ribechini E; Eckert I; Beilhack A; Du Plessis N; Walzl G; Schleicher U; Ritter U; Lutz MB
    JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased classical monocytes and CD163 expression in TB patients: an indicator of drug resistance.
    Shahzad F; Bashir N; Ali A; Jabeen S; Kashif M; Javaid K; Tahir R; Abbas A; Jahan S; Afzal N
    Braz J Microbiol; 2021 Jun; 52(2):607-617. PubMed ID: 33586094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive myeloid cells in SARS-CoV-2 and
    Shaw JA; Malherbe ST; Walzl G; du Plessis N
    Front Immunol; 2023; 14():1222911. PubMed ID: 37545508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.